Multicenter retrospective cohort study demonstrates superior safety profile of indobufen over aspirin for Post-CABG antiplatelet therapy

• Autori principali: Yu Ren (Autore), Yanwu Zhu (Autore), Qiaoyan Yan (Autore), Hui Jin (Autore), Hua Luo (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2024-09-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

ObjectivesCoronary artery bypass grafting (CABG) is essential for treating coronary artery disease, with postoperative aspirin crucial to prevent graft restenosis. However, its gastrointestinal side effects may limit tolerability in some patients. Indobufen presents a potential alternative, but its...